MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

47.89
-0.20
-0.42%
Closed 16:00 11/25 EST
OPEN
47.77
PREV CLOSE
48.09
HIGH
47.90
LOW
47.50
VOLUME
24
TURNOVER
--
52 WEEK HIGH
49.17
52 WEEK LOW
30.30
TOTAL ASSET
220.63M
YTD YIELD
-4.44%
1D
5D
1M
3M
1Y
5Y
News
Performance
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
The pharmaceutical industry has delivered a C$1 billion ($761 million) proposal to the Canadian government in an attempt to stave off an upcoming price crackdown, Reuters reported 
Benzinga · 11/15 16:19
Healthcare: XLV Survey For October
A dashboard with metrics in healthcare industries.Value and quality scores, and their evolution since last month.A list of cheap stocks.
Seekingalpha · 10/18 19:46
Pharma Stocks Poised to Move Higher
Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.
Investopedia · 10/14 13:01
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0523
SPDR S&P Pharmaceuticals ETF (XPH) - $0.0523.30-Day SEC Yield of 0.42% as of Sept. 18.Payable Sep 24; for shareholders of record Sep 22; ex-div Sep 21.
Seekingalpha · 09/21 19:14
Trump signs series of executive orders aimed at lowering drug costs
The orders, which are subject to regulatory review, are designed to bring U.S. drug prices at least on par with their costs overseas.
CNBC.com · 07/24 19:53
Healthcare Dashboard For July
Seeking Alpha - Article · 07/21 16:35
FDA to resume on-site inspections in U.S.
Seeking Alpha - Article · 07/10 16:43
Eli Lilly Q1 Earnings Call Key Takeaways
Seeking Alpha - Article · 04/27 11:22
More
No Data
Learn about the latest financial forecast of XPH. Analyze the recent business situations of SPDR® S&P Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-0.3793%
--
3-Month
0.4992%
--
6-Month
5.0086%
--
1-Year
-4.4365%
--
3-Year
1.2186%
--
5-Year
-3.5232%
--
10-Year
9.8792%
--
Since Inception
9.4359%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Risk
Low risk
Inception Date
2006-06-19
Benchmark
Dow Jones US Healthcare TR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Richardson